Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Scopolamine is an oral, intravenous, ophthalmic or topical drug derived from plants of the nightshade family (Solanaceae), specifically Hyoscyamus Niger and Atropa belladonna, with anticholinergic, antiemetic and antivertigo properties.
It has applications in prevention of nausea, vomiting, and dizziness associated with motion sickness and recovery from anesthesia and surgery. Scopolamine may also be used to treat certain stomach or intestinal problems, such as spastic muscle states, diverticulitis, irritable bowel syndrome, Parkinson-like conditions etc.
Market Dynamics
Changing lifestyle that involves minimal or absolutely no physical work in a routine life are responsible for the malfunctioning of the digestive as well as gastrointestinal system. Increasing number of population adopting long-hour sedentary work lifestyle are likely to be affected with gastrointestinal disorders such as irritable bowel syndrome and thus are responsible to support growth of the global scopolamine market.
However, various side-effects observed while using these drugs such as retarded motion, drowsiness, and diluted pupils, may limit their growth to some extent in the near future.
Key features of the study:
This report provides in-depth analysis of the scopolamine market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global scopolamine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Baxter International Inc., GlaxoSmithKline plc, Novartis AG, Perrigo Company plc, Caleb Pharmaceuticals, Inc., Myungmoon Pharma Co. LTD., Alchem International, Phytex Australia, Centroflora-Cms, Alkaloids of Australia, and Fine Chemicals Corporation.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global scopolamine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for scopolamine market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Scopolamine Market, By Dosage Form:
Tablet
Syrup
Injection
Patch
Others
Global Scopolamine Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Scopolamine Market, By Region:
North America
By Country:
U.S.
Canada
By Dosage Form:
Tablet
Syrup
Injection
Patch
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Dosage Form:
Tablet
Syrup
Injection
Patch
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Dosage Form:
Tablet
Syrup
Injection
Patch
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Dosage Form:
Tablet
Syrup
Injection
Patch
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Dosage Form:
Tablet
Syrup
Injection
Patch
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Africa
By Country:
South Africa
Central Africa
North Africa
By Dosage Form:
Tablet
Syrup
Injection
Patch
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Company Profiles
Baxter International Inc.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
GlaxoSmithKline plc
Novartis AG
Perrigo Company plc.
Caleb Pharmaceuticals, Inc.
Myungmoon Pharma Co. LTD.
Alchem International
Phytex Australia
Centroflora-Cms
Alkaloids of Australia
Fine Chemicals Corporation
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Dosage Form
o Market Snippet, By Distribution Channel
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Epidemiology
o Historical Overview
o Revenue Potential of Drugs
o PORTER'S Five Forces
o PEST Analysis
4. Global Scopolamine Market, By Dosage Form, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Tablet
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Syrup
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Injection
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Patch
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
5. Global Scopolamine Market, By Distribution Channel, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Hospital Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Retail Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Online Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
6. Global Scopolamine Market, By Regions, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2016 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Northern Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Baxter International Inc.
o Company Overview
o Dosage Form Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o GlaxoSmithKline plc
o Company Overview
o Dosage Form Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Novartis AG
o Company Overview
o Dosage Form Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Perrigo Company plc.
o Company Overview
o Dosage Form Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Caleb Pharmaceuticals, Inc.
o Company Overview
o Dosage Form Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Myungmoon Pharma Co. LTD.
o Company Overview
o Dosage Form Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Alchem International
o Company Overview
o Dosage Form Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Phytex Australia
o Company Overview
o Dosage Form Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Centroflora-Cms
o Company Overview
o Dosage Form Portfolio
o Financial Performance
o Recent Highlights
o Alkaloids of Australia
o Company Overview
o Dosage Form Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Fine Chemicals Corporation
o Company Overview
o Dosage Form Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
8. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 19 market data tables and 23 figures on "Scopolamine Market" - Global forecast to 2026".
